Pharma & Biotech

After an impressive rally, Medpace shares are showing initial signs of fatigue. The clinical research organization's stock closed Friday's session...

While ClearPoint Neuro's stock experienced a minor decline in Friday's trading session, substantial institutional investors are demonstrating pronounced bullish sentiment....

Biotechnology firm Arvinas is undergoing a significant strategic pivot, marked by a comprehensive restructuring plan that has placed its shares...

Reviva Pharmaceuticals Holdings Inc. witnessed a sharp decline in its share price after unveiling plans to raise $9 million through...

Syndax Pharmaceuticals stands at a pivotal juncture, with a significant regulatory decision for its flagship cancer therapy scheduled for late...

Shares of Viking Therapeutics experienced substantial gains following the release of impressive Phase 2 trial results for its oral formulation...

Altimmune finds itself navigating turbulent waters as multiple class-action lawsuits cast a shadow over the company's stock performance. The litigation...

Pulse Biosciences, a prominent biotechnology firm, experienced significant volatility as a wave of insider selling activity followed a period of...

Neogenomics shares are experiencing significant turbulence as the company navigates disappointing quarterly results, intensifying competitive pressures, and a major patent...

Arrowhead Pharmaceuticals has emerged as a compelling story within the biotechnology sector, capturing significant investor attention. The recent substantial appreciation...